Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
PCCRAYT
Stock Latest News
Private Companies
C Ray Therapeutics Expands Isotope Access and Chengdu Hub Strategy to Cement Radiopharma Role
6d ago
CRAYT
Premium
Private Companies
C Ray Therapeutics Positions Chengdu Hub as Integrated Radiopharmaceutical CRDMO Platform
9d ago
CRAYT
Premium
Private Companies
C Ray Therapeutics Highlights Integrated Radiopharmaceutical Hub Strategy in Chengdu
9d ago
CRAYT
Premium
Private Companies
C Ray Therapeutics Secures Exclusive Lu-177 Deal as It Deepens Role in China’s Radiopharma Supply Chain
13d ago
CRAYT
Premium
Private Companies
C Ray Therapeutics Forms Strategic Lu-177 Supply Partnership in China
14d ago
CRAYT
Premium
Private Companies
C Ray Therapeutics, SHINE Technologies Form Lu-177 Supply Partnership in China
15d ago
CRAYT
Premium
Private Companies
C-Ray Therapeutics Secures Exclusive Lu-177 Supply Rights for Mainland China Through SHINE Deal
15d ago
CRAYT
Premium
Private Companies
Radioligand Therapy Platform Innovation Spotlighted at XDC 2026
17d ago
CRAYT
Premium
Private Companies
C Ray Therapeutics Highlights Emerging Protein Scaffolds in Radioligand Therapy
18d ago
CRAYT
Premium
Private Companies
Radiopharma Supply Chain and Isotope Purity Emerge as Strategic Focus for C Ray Therapeutics
19d ago
CRAYT
Premium
Private Companies
C Ray Therapeutics Expands Radiopharma Role With Isotope Supply, Automation, and Localized Alpha Therapy Focus
20d ago
CRAYT
Premium
Private Companies
C Ray Therapeutics Highlights Supply-Chain Push for Actinium-225 and Radiopharma Scale-Up
21d ago
CRAYT
Premium
Private Companies
C Ray Therapeutics Highlights Actinium-225 Supply Chain Strategy Around XDC 2026
22d ago
CRAYT
Premium
Private Companies
C Ray Therapeutics Highlights Automation Partnerships in Radiopharmaceutical Manufacturing
23d ago
CRAYT
Premium
Private Companies
C Ray Therapeutics Highlights Automation Partners in Radiopharmaceutical Manufacturing
24d ago
CRAYT
Premium
Private Companies
C Ray Therapeutics Highlights Lead-212 Supply Challenges and Thorium-Based Production Model
24d ago
CRAYT
Premium
Private Companies
C Ray Therapeutics Strengthens Radiopharma Platform With AAALAC Accreditation and Focus on Localized Alpha Therapies
27d ago
CRAYT
Premium
Private Companies
Localized Alpha Therapy for Peritoneal Metastases Draws Strategic Focus at XDC 2026
27d ago
CRAYT
Premium
Private Companies
C Ray Therapeutics Emphasizes Localized Alpha Therapy and Manufacturing Needs in Peritoneal Cancer
28d ago
CRAYT
Premium
Private Companies
C Ray Therapeutics Bolsters Global Radiopharma Credentials With AAALAC Accreditation and Regulatory Strategy Focus
1M ago
CRAYT
Premium
Private Companies
C Ray Therapeutics Secures AAALAC Accreditation and Sharpens Radiopharma Strategy in China
1M ago
CRAYT
Premium
Private Companies
C Ray Therapeutics Highlights Early-Stage Strategy Trends in Radiopharmaceutical Development
1M ago
CRAYT
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
